Get Fit Bharat

Tag: Training

HomeTraining

Ayanika, a brand renowned for its exquisite, concept-driven lab grown diamond jewelry collections, is proud to announce the grand opening of its flagship store at Laxmi Industrial Estate, Andheri. With a vision to redefine luxury, Ayanika blends artistry, craftsmanship, and personalization to offer customers a truly unique jewelry experience.   …

The Nomination Committee of Eastnine AB proposes that the current Board member Louise Richnau is elected Chairman of the Board at Eastnine's Annual General Meeting on April 29, 2025. Liselotte Hjorth, current Chairman of the Board of Eastnine, has informed the Nomination Committee that she declines re-election. Liselotte Hjorth has been …

Dynavox Group (previously Tobii Dynavox) will publish the 2024 year-end report on February 5 at 07.30 a.m. CET. Following this report, at 09.00 a.m. CET, Dynavox Group will host a webcast for investors, analysts and media.  Dynavox Group’s President and CEO Fredrik Ruben and CFO Linda Tybring will present and …

Nordea Bank Abp Stock exchange release – Total number of voting rights and capital 21 January 2025 at 9.15 EET Nordea has today cancelled 4,841,641 treasury shares in line with the decision by the Board of Directors. The shares were held for capital optimisation purposes and acquired through share buy-backs. …

Several of the world’s major cities already feature a Paradox Museum that challenges visitors' senses and sparks their playfulness. In autumn 2025, Gothenburg will open its own museum after Hufvudstaden has signed a lease agreement with Paradox Museum for 760 square meters on the upper floor of the Femman shopping …

Halton, a global technology leader in demanding indoor air solutions commits to set a near-term science-based target as well as a net zero target aligned with the requirements of the Science-Based Targets initiative (SBTi). Halton’s commitment includes reducing its Scope 1 and Scope 2 emissions, and engaging with its suppliers to …

Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, announces that the first two patients have been treated in the company’s Phase I/II clinical trial. The trial investigates the safety and tolerability of a new, tailored treatment for advanced colorectal cancer, a disease with significant medical needs …